Detail akcie Perrigo online

Business Summary: Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Perrigo Company PLC revenues increased 5% to $4.66B. Net loss before extraordinary items decreased 97% to $4.4M. Revenues reflect CSCI segment increase of 11% to $1.69B, CSCA segment increase of 1% to $2.96B, Europe segment increase of 10% to $1.62B, United States segment increase of 2% to $2.92B, All other countries segment increase of 8% to $116.3M.